Omnicell Closes USD 100m Acquisition of Speciality Pharmacy Management Services Provider ReCept.

MANews-(C)2009-2021

California-based medical management solutions provider Omnicell, Inc. (NASDAQ: OMCL) has closed the acquisition of Texas-based speciality pharmacy management services provider ReCept Holdings, Inc. for USD 100m, the company said.

Under the terms of the agreement, Omnicell will pay total aggregate cash consideration of USD 100m.

ReCept business that is being acquired recorded approximately USD 24m of total revenue (unaudited) for the 12 months ended September 30, 2021.

Omnicell will use cash available on its balance sheet to fund the transaction. Upon closing, the transaction is expected to be accretive to Omnicell's non-GAAP EBITDA beginning in the first quarter of 2023.

The acquisition will broaden Omnicell's portfolio of capabilities and services to address the significant need to improve access to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT